Spur cell anemia associated with a cirrhotic non-alcoholic steatohepatitis patient

Hepatology Research

Volumn 37, Issue 6, 2007, Pages 482-485

  Haruta, Ikuko ^a   Hashimoto, Etsuko ^a   Kabutake, Ayae ^a   Taniai, Makiko ^a   Tokushige, Katsutoshi ^a   Shiratori, Keiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACANTHOCYTOSIS; ADULT; ARTICLE; AUTOPSY; CASE REPORT; DEATH; DETERIORATION; DISEASE ASSOCIATION; DISEASE COURSE; ECHOGRAPHY; FOLLOW UP; GIEMSA STAIN; HEMOLYTIC ANEMIA; HEPATIC ENCEPHALOPATHY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; JAUNDICE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER NODULE; MALE; MALLORY BODY; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; SPLENOMEGALY; SPUR CELL ANEMIA; UNCONSCIOUSNESS;

EID: 34250364074     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00037.x     Document Type: Article

References (15)

1. Doll DC, Doll NJ. Spur cell anemia. South Med J 1982; 75: 1205-10.
2. Ludwig J, Viggiano T, Mcgill D et al. Non-alcoholic steatohepatitis. Mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-8.
3. Suzuki D, Hashimoto E, Kaneda H et al. Liver failure caused by non-alcoholic steatohepatitis in an obese young male. J Gastroenterol Hepatol 2005; 20: 327-9.
4. Hashimoto E, Taniai M, Kaneda H et al. Comparison of hepatocellular carcinoma patients with alcoholic liver disease and non-alcoholic steatohepatitis. Alcohol Clin Exp Res 2004; 28: 164S-168 S.
5. Shimada M, Hashimoto E, Taniai M et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002; 37: 154-60.
6. Sanyal AJ, Banas C, Sargeant C et al. Similarities and differences in outcomes of cirrhosis due to non-alcoholic steatohepatitis and hepatitis C. Hepatol 2006; 43: 682-9.
7. Cooper RA, Kimball DB, Duocher JR. Role of the spleen in membrane conditioning and hemolysis of spur cells in liver disease. N Engl J Med 1974; 290: 1279-84.
8. Cooper RA. Hemolytic syndromes and red cell membrane abnormality in liver disease. Semin Hematol 1980; 17: 103-12.
9. Harrison SA, Kadakia S, Lang KA et al. Non-alcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol 2002; 97: 2714-24.
10. Adams LA, Angulo P, Lindor KD. Non-alcoholic fatty liver disease. CMAJ 2005; 172: 899-905.
11. Mari M, Caballero F, Colell A et al. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab 2006; 4: 185-98.
12. Shima Y, Tsukada T, Nakanishi K et al. Association of theTrp64 Arg mutation of the beta3-adrenergic receptor with fatty liver and mild glucose intolerance in Japanese subjects. Clin Chim Acta 1998; 274: 167-76.
13. Murata C, Watanabe T, Furuya H et al. Aldehyde dehydrogenase 2 and β3-adrenergic receptor gene polymorphisms: Their association with elevated liver enzymes and metabolic syndrome. Metabolism 2003; 52: 1096-101.
14. Namikawa C, Shu-Ping Z, Vyselaar JR et al. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J Hepatol 2004; 40: 781-6.
15. Nozaki Y, Saibara T, Nemoto Y et al. Polymorphisms of interleukin-1 beta and beta 3-adrenergic receptor in Japanese patients with non-alcoholic steatohepatitis. Alcohol Clin Exp Res 2004; 28 (Suppl 8): 106S-110S.